This peptide is a growth hormone-releasing hormone (GHRH) fragment that includes the first 29 amino acids of its N-terminus and an amidation at its C-terminus
BPC-157 is prohibited under WADA as an unapproved substance and it is explicitly listed on the NCAA banned substances list
Additionally, interactions with concurrent medications (lipid-lowering agents, diabetes medications, stimulants) have not been systematically evaluated
Cagrilintide is an investigational amylin analog and is not approved by the FDA, EMA, or comparable regulators for any indication
When paired with MIC nutrients (Methionine, Inositol, Choline), it can support fat breakdown, energy production, and overall metabolic health
Regenerative peptides and vascular remodeling in preclinical recovery models